Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 6/20 | 0.40 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.38 |
| ▸ | GPR3 | P46089 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13865816 | 0.88 | PABPC1 (0.44) | GGPS1LMNAL3MBTL1PABPC1KMT2A | |
| Trifluoromethanesulfonic Acid SCHEMBL3629145 | 0.86 | KCNH2 (0.44) | KCNH2GGPS1LMNAL3MBTL1PABPC1 | |
| Trifluoromethanesulfonic Acid SCHEMBL306405 | 0.83 | KCNH2 (0.46) | KCNH2GGPS1LMNAL3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL30330385 | 0.83 | KCNH2 (0.46) | KCNH2GGPS1LMNAL3MBTL1 | |
| Trifluoromethanesulfonic Acid SCHEMBL6522138 | 0.82 | KCNH2 (0.40) | KCNH2ACHEGPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL11889602 | 0.82 | GGPS1 (0.48) | KCNH2GGPS1LMNAL3MBTL1PABPC1 | |
| Trifluoromethanesulfonic Acid SCHEMBL5674252 | 0.81 | LMNA (0.53) | KCNH2GGPS1LMNAL3MBTL1PABPC1 | |
| Trifluoromethanesulfonic Acid SCHEMBL29396207 | 0.81 | KCNH2 (0.50) | KCNH2LMNAACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL295685 | 0.81 | KCNH2 (0.50) | KCNH2LMNAACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL23004387 | 0.80 | KCNH2 (0.52) | KCNH2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050175867-A1 | Mixture of two or more organic salts; reduced melting point; low temperature stability; polymer electrolyte fuel cells, dye sensitized solar cells, biological batteries | DAIKIN INDUSTRIES, LTD (JP) | 2005-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050175867-A1 | Mixture of two or more organic salts; reduced melting point; low temperature stability; polymer electrolyte fuel cells, dye sensitized solar cells, biological batteries | CA2, CA12, CA4 | KCNH2 435/4885GGPS1 3322/4885LMNA 3394/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.